| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 904,959 | 0 |
| Net increase (decrease) in cash | 231,083 | 32,640 |
| Cash and cash equivalents at beginning of period | 283,714 | - |
| Cash and cash equivalents at end of period | 514,797 | - |
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)